551 related articles for article (PubMed ID: 31812439)
21. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
22. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
[TBL] [Abstract][Full Text] [Related]
23. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
Qin X; Lu M; Zhou Y; Li G; Liu Z
Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
25. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
26. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
27. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
29. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
[TBL] [Abstract][Full Text] [Related]
30. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
[TBL] [Abstract][Full Text] [Related]
31. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
[TBL] [Abstract][Full Text] [Related]
32. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
[TBL] [Abstract][Full Text] [Related]
33. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
34. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.
Deng X; Jiang P; Chen J; Li J; Li D; He Y; Jiang Y; Zhang Y; Xu S; Li X; Wang S; Tian F
Cell Death Dis; 2020 Oct; 11(10):860. PubMed ID: 33060563
[TBL] [Abstract][Full Text] [Related]
35. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
Chang W; Wang Y; Li W; Geng Z
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
[TBL] [Abstract][Full Text] [Related]
37. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
38. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma.
Meng FT; Huang M; Shao F; Huang Q
Cancer Biomark; 2018; 23(3):353-361. PubMed ID: 30248044
[TBL] [Abstract][Full Text] [Related]
39. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
Janthamala S; Jusakul A; Kongpetch S; Kimawaha P; Klanrit P; Loilome W; Namwat N; Techasen A
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2049-2059. PubMed ID: 34283274
[TBL] [Abstract][Full Text] [Related]
40. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
Jiang T; Wang C; Zhu Y; Han H
J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
